GLP-1 Agonists May Reduce Risk of Alcohol Use Disorder Hospitalizations

被引：0
|
作者：
Anderer, Samantha
机构：
来源：
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION | 2025年 / 333卷 / 03期
关键词：
D O I：
10.1001/jama.2024.25503
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Effects of GLP-1 Receptor Agonists in Alcohol Use Disorder
    Klausen, Mette Kruse
    Knudsen, Gitte Moos
    Vilsboll, Tina
    Fink-Jensen, Anders
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2025, 136 (03)
  • [2] Use of GLP-1 receptor agonists in the treatment of alcohol and cocaine use disorder
    Orbanic, Ante
    Pecek, Mirta
    Tomasic, Lea
    Samle, Ivona
    Petrovic, Zrnka Kovacic
    Jaksic, Vlatka Pandzic
    BRITISH JOURNAL OF PHARMACOLOGY, 2023, 180 : 258 - 259
  • [3] GLP-1 Receptor Agonists: Promising Therapeutic Targets for Alcohol Use Disorder
    Jerlhag, Elisabet
    ENDOCRINOLOGY, 2025, 166 (04)
  • [4] Risk of thyroid cancer with the use of GLP-1 receptor agonists
    Gouverneur, Amandine
    Penichon, Marine
    Garrel, Renaud
    Hillaire-Buys, Dominique
    Pariente, Antoine
    Faillie, Jean-Luc
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2021, 30 : 330 - 330
  • [5] Impact of GLP-1 Receptor Agonists on Alcohol-Related Liver Disease Development and Progression in Alcohol Use Disorder
    Kuo, Chia-Chih
    Li, Chun-Hsien
    Chuang, Min-Hsiang
    Huang, Po-Yu
    Kuo, Hsing-Tao
    Lai, Chih-Cheng
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2025,
  • [6] GLP-1 and dual GIP/GLP-1 receptor agonists increase risk of aspiration
    Reactions Weekly, 2025, 2044 (1) : 3 - 3
  • [7] Inquiries Into the Mechanisms by Which GLP-1 Receptor Agonists Reduce Cardiovascular Risk in Diabetes
    Inzucchi, Silvio E.
    Arai, Andrew E.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2024, 84 (06) : 558 - 560
  • [8] GLP-1 receptor agonists are promising but unproven treatments for alcohol and substance use disorders
    Leggio, Lorenzo
    Hendershot, Christian S.
    Farokhnia, Mehdi
    Fink-Jensen, Anders
    Klausen, Mette Kruse
    Schacht, Joseph P.
    Simmons, W. Kyle
    NATURE MEDICINE, 2023, 29 (12) : 2993 - 2995
  • [9] GLP-1 receptor agonists are promising but unproven treatments for alcohol and substance use disorders
    Lorenzo Leggio
    Christian S. Hendershot
    Mehdi Farokhnia
    Anders Fink-Jensen
    Mette Kruse Klausen
    Joseph P. Schacht
    W. Kyle Simmons
    Nature Medicine, 2023, 29 : 2993 - 2995
  • [10] Use of GLP-1 agonists for weight loss increases risk of GI AEs
    Reactions Weekly, 2023, 1978 (1) : 12 - 12
12345